Wisepowder has a full range of raw materials of Aging& Antiaging , and has a total quality management system.

Ifihan 1-4 ni awọn abajade 13

1 2 3 4

Aging& Antiaging(Anti-aging)

Ogbo jẹ nkan ti gbogbo wa ṣe ṣugbọn oye diẹ nipa. Opo rẹ ni awọn ayipada bi o ti di ọjọ-ori ti o le ni awọn ipa kekere lori iranti rẹ tabi awọn ọgbọn ero O rọrun lati ṣe atokọ ti gbogbo awọn ayipada ti o wa pẹlu ọjọ-ori - iranti pipadanu, awọn wrinkles, isonu iṣan.
Antiaging (egboogi-ti ogbo) le jẹ akọle ti o nira lati koju: ogun Lọwọlọwọ ja lori itumo ọrọ naa ni iwadii ati oogun, ati bi ami fun awọn ọja ni okunagbara ati nigbagbogbo jegudujera
Antiaging (Anti-ti ogbo) ni bayi ni awọn nọmba ti o tumọ si awọn itumo wọpọ ati awọn itọkasi.
-Ninu iwadi ti egboogi-ti ogbo (antiaging) iwadi ti tọka si iyasọtọ, idiwọ, tabi yiyipada ilana ti ogbo. Lakoko ti ọjọ iwaju n wa ni ileri pupọ, lasiko ko si iṣeduro ati imọ ẹrọ iṣoogun ti o wa ti o fa fifalẹ tabi ṣe iyipada ọjọ ogbó ninu eniyan.
-In the medical and reputable business community, anti-aging medicine means the early detection, prevention, and treatment of age-related diseases. This is quite different from tackling the aging process itself, and a wide array of strategies and therapies are currently available. For example Alzheimer’s treatment, disease which is relate to aging.
-Ni agbegbe iṣowo ti o gbooro - eyiti o pẹlu ọpọlọpọ awọn arekereke tabi awọn afowopaowo alailowaya - egboogi-ti ogbo jẹ ami ti o niyelori ati ọna afihan lati mu alekun awọn tita.

Antiaging powder application

Ninu aṣa yii, awọn ọja egboogi ti n di pupọ ati gbajumọ. Ohun elo lulú ti Antiaging ni:
-Skin awọn ọja itọju
-Awọn ọja ilera
-Amu ọti oyinbo mimu
-Awọn ọja ọja
Aging&Alzheimer’s treatment
Dementia di wọpọ pẹlu ọjọ-ori.Fun 3% ti awọn eniyan laarin awọn ọjọ-ori ti 65 ati 74, 19% laarin 75 ati 84, ati pe o fẹrẹ to idaji awọn ti o ju ọdun 85 lọ ni ibajẹ. Awọn sakani iwoye naa lati ailera ailera ti o lọra si neurodegenerative awọn arun ti arun Alzheimer, arun cerebrovascular, Arun Parkinson ati aisan Lou Gehrig.
Ogbo jẹ ifosiwewe eewu akọkọ fun aisan Alzheimer. Alzheimer jẹ iru iyawere ti o fa awọn iṣoro pẹlu iranti, ironu ati ihuwasi. Awọn aami aisan Alzheimer nigbagbogbo dagbasoke laiyara ati ki o buru si lori akoko, di pupọ to lati dabaru pẹlu awọn iṣẹ ṣiṣe ojoojumọ. “A mọ pe ọjọ-ori jẹ ipin idasi nla ti o tobi julọ si Alzheimer, nitorinaa ko ṣe iyalẹnu pe a wa ibi-afẹde oogun kan ti o tun jẹ ki o dagba,”
FDA tun fọwọsi bii Namzaric, apapọ kan ti Namenda (memantine) ati Aricept, fun itọju iwọntunwọnsi si arun Alzheimer ti o lagbara.
Namendais (memantine) gbagbọ lati ṣiṣẹ nipasẹ ṣiṣe ilana iyọjẹ, kemikali ọpọlọ pataki. Nigbati a ba ṣejade ni iwọn lilo to gaju, giluteni le yori si iku sẹẹli. Nitori awọn antagonists NMDA ṣiṣẹ yatọ si awọn inhibitors cholinesterase, awọn iru oogun meji ni a le fun ni aṣẹpọ.
Many new products are known to be useful in treating Alzheimer’s disease. Such as J-147 powder, CMS121 powder.

Antiaging powder products

J-147 powder(1146963-51-0): J147 is something of a modern elixir of life,it’s been shown to treat Alzheimer’s disease and reverse aging in mice and is almost ready for clinical trials in humans.The team is already performing additional studies on the molecules that are altered by J147’s effect on the mitochondrial ATP synthase—which could themselves be new drug targets. J147 has completed the FDA-required toxicology testing in animals.
Alpha-lipoic acid powder(1077-28-7): Alpha-lipoic acid is a vitamin-like chemical called an antioxidant,which means that it might provide protection to the brain under conditions of damage or injury.
Alpha-lipoic acid dabi ẹni pe o ṣe iranlọwọ lati yago fun awọn iru awọn ibajẹ sẹẹli ninu ara, ati tun mu awọn ipele Vitamin bii Vitamin E ati Vitamin C. Iwe-ẹri tun wa pe alpha-lipoic acid le ṣe ilọsiwaju iṣẹ ati adaṣe awọn neurons ninu àtọgbẹ.
Iṣe iranti jẹ ibakcdun ti o wọpọ laarin awọn agbalagba agbalagba.O ti gbagbọ pe ibajẹ lati aapọn ipanilara ṣe ipa pataki ninu pipadanu iranti.
Nitori alpha-lipoic acid jẹ apanirun ti o lagbara, awọn ijinlẹ ti ṣe ayewo agbara rẹ lati fa fifalẹ ilọsiwaju ti awọn rudurudu ti o jẹ ti iranti iranti, gẹgẹ bi aisan Alzheimer.
Iwukara, ẹdọ, iwe kidirin, owo, broccoli, ati awọn poteto jẹ awọn orisun to dara ti alpha-lipoic acid.
CMS121 powder(1353224-53-9): Geroprotectors are substances which have the potential to slow down the rate at which an animal ages by targeting the aging processes. The new study examines a number of compounds and identifies some that protect the neurons from harm by slowing down an aging process; the researchers named these compounds geroneuroprotectors.
Nipa lilo awọn iṣiro wọnyi gẹgẹbi ipilẹ, awọn oniwadi ṣẹda awọn oludibo oogun Alzheimer mẹta ti a pe ni CMS121, CAD31, ati J147; wọn tun lo fisetin ati curcumin taara. Ẹgbẹ naa ṣe afihan pe gbogbo marun ti awọn iṣọpọ wọnyi dinku biomarkers ti ogbó, pọ si igbesi aye agbedemeji ti awọn eku ati awọn fo, ati dinku awọn ami ti iyawere.

Occurrence of aging

Ti ogbo ni ipa ti akoko lori ara eniyan, ati pe o waye lori awọn ipele pupọ:
-Agbo agbalagba. Ọjọ ori awọn sẹẹli da lori iye awọn akoko ti wọn ti tun ṣe. Ẹka kan le ṣe ẹda bii igba 50 ṣaaju ohun elo jiini ko si ni anfani lati daakọ ni deede, eyiti o jẹ nitori awọn telomeres kukuru. Bibajẹ diẹ ti o ṣe si awọn sẹẹli nipasẹ awọn ipilẹ awọn ọfẹ ati awọn ifosiwewe miiran, awọn sẹẹli diẹ sii nilo lati tun ṣe.
-Agbo agbalagba. Awọn homonu ṣe ipa nla ninu ti ogbo, paapaa lakoko idagbasoke ọmọde ati idagbasoke idagbasoke ti ọdọ. Awọn ipele homonu n yipada nipasẹ igbesi aye. Ọdọmọkunrin mu irorẹ ati awọn pores nla. Bi a ṣe n dagba, awọn ayipada homonu yorisi awọ ti o gbẹ ati menopause.
-Awọn bibajẹ. Ibajẹ akopọ ni gbogbo ita. Ifihan si majele, oorun, awọn ounjẹ ipalara, idoti, ati ẹfin mu eewu lori ara. Ni akoko pupọ, awọn okunfa ita wọnyi le ja si ibajẹ ara ati pe ara ṣubu lulẹ ni agbara rẹ lati ṣetọju ati tunṣe awọn sẹẹli, awọn ara, ati awọn ara.
-Biwaju agbalagba. Bi o ṣe n ṣe ọjọ rẹ, awọn sẹẹli rẹ ti n tan ounje nigbagbogbo sinu agbara, eyiti o ṣe agbejade awọn iṣelọpọ ti o le ṣe ipalara. Ilana ti metabolizing ati ṣiṣẹda awọn abajade agbara ni ibajẹ si ara lori akoko. Diẹ ninu awọn gbagbọ pe fa fifalẹ ilana ilana iṣelọpọ nipasẹ awọn iṣe bii ihamọ kalori le fa fifalẹ ọjọ-ori ninu eniyan.
Awọn ami ihuwasi ihuwasi ti Alzheimer wọpọ pẹlu oorun sisun, rin kiri, aitasera, aibalẹ, ibinu, isinmi, ati ibanujẹ. Awọn onimo ijinlẹ sayensi n kọ idi idi ti awọn aami aiṣan wọnyi fi n ṣẹlẹ ati pe wọn nkọ awọn itọju tuntun — oogun ati aarun — lati ṣakoso wọn.

Reference:

  1. Mortimer RK, Johnston JR (1959). “Life Span of Individual Yeast Cells”. Nature. 183 (4677): 1751–1752. Bibcode:1959Natur.183.1751M. doi:10.1038/1831751a0. hdl:2027/mdp.39015078535278. PMID 13666896
  2. Experimental drug targeting Alzheimer’s disease shows anti-aging effects” (Press release). Salk Institute. 12 November 2015. Retrieved November 13, 2015.
  3. Researchers identify the molecular target of J147, which is nearing clinical trials to treat Alzheimer’s disease”. Retrieved 2018-01-30.
  4. Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature Peter T. Nelson, Irina Alafuzoff, Eileen H. Bigio, Constantin Bouras, Heiko Braak, Nigel J. Cairns, Rudolph J. Castellani, Barbara J. Crain, Peter Davies, Kelly Del Tredici, Charles Duyckaerts, Matthew P. Frosch, Vahram Haroutunian, Patrick R. Hof, Christine M. Hulette, Bradley T. Hyman, Takeshi Iwatsubo, Kurt A. Jellinger, Gregory A. Jicha, Enikö Kövari, Walter A. Kukull, James B. Leverenz, Seth Love, Ian R. Mackenzie, David M. Mann, Eliezer Masliah, Ann C. McKee, Thomas J. Montine, John C. Morris, Julie A. Schneider, Joshua A. Sonnen, Dietmar R. Thal, John Q. Trojanowski, Juan C. Troncoso, Thomas Wisniewski, Randall L. Woltjer, Thomas G. Beach J Neuropathol Exp Neurol. Author manuscript; available in PMC 2013 Jan 30. Published in final edited form as: J Neuropathol Exp Neurol. 2012 May; 71(5): 362–381. doi: 10.1097/NEN.0b013e31825018f7